A Case Report of Calcium- Sensing Receptor Gene Variant CASR (c.659G>A; p.R220Q) and Primary Hyperparathyroidism
Advances in Diabetes & Endocrinology · 2022
DOI: 10.13188/2475-5591.1000017 ↗Kurz gefasst
Fallbericht in der Zeitschrift Advances in Diabetes & Endocrinology, 2022. Verfasst von ME Fang.
Abstract (Originalsprache)
Background: Primary hyperparathyroidism (PHPT) results from excessive parathyroid hormone from one or more overactive parathyroid gland(s). An estimated 90% of PHPT cases are sporadic, and up to 10% are inherited, comprising hereditary hyperparathyroidism (HHPT). Genetic testing can aid in diagnosis and management and influence testing of other family members.
Zitieren
APA
Fang, M. (2022). A Case Report of Calcium- Sensing Receptor Gene Variant CASR (c.659G>A; p.R220Q) and Primary Hyperparathyroidism. Advances in Diabetes & Endocrinology. https://doi.org/10.13188/2475-5591.1000017
Vancouver
Fang M. A Case Report of Calcium- Sensing Receptor Gene Variant CASR (c.659G>A; p.R220Q) and Primary Hyperparathyroidism. Advances in Diabetes & Endocrinology. 2022. doi:10.13188/2475-5591.1000017
BibTeX
@article{Fang2022,
author = {Fang, ME},
title = {A Case Report of Calcium- Sensing Receptor Gene Variant CASR (c.659G>A; p.R220Q) and Primary Hyperparathyroidism},
journal = {Advances in Diabetes & Endocrinology},
year = {2022},
doi = {10.13188/2475-5591.1000017}
}
EUVIMED